SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

OS Therapies Inc
Date: Aug. 8, 2025 · CIK: 0001795091 · Accession: 0001213900-25-073722

Offering / Registration Process Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289216

Date
August 12, 2025
Author
OS Therapies Incorporated
Form
CORRESP
Company
OS Therapies Inc

Letter

Re: OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-289216)

August 8, 2025

VIA EDGAR

U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn.: Doris Stacey Gama Office of Life Sciences

Ladies and Gentlemen:

On behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.

Please advise the undersigned of the effectiveness of the Registration Statement.

Very truly yours,

/s/ Spencer G. Feldman

Spencer G. Feldman

cc: Paul A. Romness, MPH

August 8, 2025

U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn.: Doris Stacey Gama Office of Life Sciences

Re: OS Therapies Incorporated Registration Statement on Form S-1 (No. 333-289216)

Ladies and Gentlemen:

OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.

Very truly yours,
OS Therapies Incorporated

Show Raw Text
CORRESP
 1
 filename1.htm

 August
8, 2025

 VIA
EDGAR

 U.S.
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:	Doris Stacey Gama
	Office of Life Sciences

 Re: OS
 Therapies Incorporated
 Registration Statement on Form S-1 (No. 333-289216)

 Ladies
and Gentlemen:

 On
behalf of OS Therapies Incorporated, a Delaware corporation (the "Company"), we enclose the Company's request for acceleration
of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.

 Please
advise the undersigned of the effectiveness of the Registration Statement.

 Very truly yours,

 /s/
 Spencer G. Feldman

 Spencer G. Feldman

 cc: Paul
 A. Romness, MPH

 August
8, 2025

 U.S.
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:	Doris Stacey Gama
	Office of Life Sciences

 Re: OS
 Therapies Incorporated
 Registration Statement on Form S-1 (No. 333-289216)

 Ladies
and Gentlemen:

 OS
Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it
will become effective at 4:30 p.m., Eastern time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.

 Very truly yours,

 OS Therapies Incorporated

 By:
 /s/
 Paul A. Romness

 Paul A. Romness

 President and Chief Executive Officer